Medigen Vaccine Biologics Corp

Biotechnology Research • 7F., No. 16, Taiwan, Province of China • 21-50 Employees

Company overview

Headquarters	7F., No. 16, Ln. 120, Sec. 1, Neihu Rd, Taipei, 114, TW
Phone number	+88636684865
Website	medigenvac.com
NAICS	541714
SIC	283
Keywords	Biotechnology And Vaccines
Founded	2012
Employees	21-50
Socials

Key Contacts at Medigen Vaccine Biologics Corp

Ching Wu

Director Of Regulatory Affairs

Jude Chen

Member Board Of Directors

Andy Chiu

Audit Director

Medigen Vaccine Biologics Corp Email Formats

Medigen Vaccine Biologics Corp uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@medigenvac.com), used 63.6% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@medigenvac.com	63.6%
{first name}{last name}	johndoe@medigenvac.com	36.4%

About Medigen Vaccine Biologics Corp

Established in 2012, Medigen Vaccine Biologics Corp (MVC) is a subsidiary of Medigen Biotechnology Corp (www.medigen.com.tw), Taipei, Taiwan. MVC develops vaccines and biosimilars for important unmet medical needs. Our focus is to deliver affordable medicines for developing countries and with a particular focus on SE Asia. We aim to become one of the leading pharmaceutical companies for Taiwan and global communities. Humanity, innovation, and quality are MVC core values. We integrate biomedical technologies to improve human health so that every person, from infants to seniors, has a chance to be free from infectious diseases. Our most advanced products are MVC-1901 and MVC-EVA71. MVC-1901 is a spike-protein-based subunit vaccine for COVID-19. Based on a very large phase 2 trial powered to assess safety and efficacy by immunobridging, the vaccine has EUA status in Taiwan. Phase 3 trials for full approval are in progress. MVC-EVC71A is an inactivated whole virus-based vaccine for enteroviral disease in children between 2 months and 12 years of age. The vaccine has recently completed a phase 3 trial and is currently in regulatory review for commercial licensing.

Medigen Vaccine Biologics Corp revenue & valuation

Annual revenue	$7,900,000
Revenue per employee	$247,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$25,300,000
Total funding	No funding

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Manager

Entry

Director

Employees by Department

Medigen Vaccine Biologics Corp has 14 employees across 5 departments.

Departments

Number of employees

Funding Data

Medigen Vaccine Biologics Corp has never raised funding before.

Medigen Vaccine Biologics Corp Tech Stack

Discover the technologies and tools that power Medigen Vaccine Biologics Corp's digital infrastructure, from frameworks to analytics platforms.

Plesk

Hosting panels

Apache HTTP Server

Web servers

reCAPTCHA

Security

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

PHP

Programming languages

Font Awesome

Font scripts

Swiper

JavaScript libraries

Google Analytics

Analytics

Bootstrap

UI frameworks

Popper

Miscellaneous

AOS

JavaScript libraries

Frequently asked questions

Medigen Vaccine Biologics Corp is located in 7F., No. 16, TW.

You can reach Medigen Vaccine Biologics Corp at +88636684865.

Medigen Vaccine Biologics Corp was founded in 2012, making it 14 years old. The company has established itself as a significant player in its industry over this time.

Medigen Vaccine Biologics Corp has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contacts at Medigen Vaccine Biologics Corp

Ching Wu

Director Of Regulatory Affairs

Jude Chen

Member Board Of Directors

Andy Chiu

Audit Director

4.8

40,000 users